Arianna Colini Baldeschi, Ph.D., graduated from University of Rome Tor Vergata (Italy) with a bachelor’s degree in biology and a master’s degree in medical biotechnology. She completed her Ph.D. degree in Molecular Biology at the International School of Advanced Studies (SISSA), Trieste (Italy), where she studied prion diseases, focusing on the role of a serine protease inhibitor in the formation and aggregation of the prion protein. Later, she moved to Barcelona (Spain), where she completed her first postdoc. There she focused on the study of alpha-synuclein aggregation in Parkinson’s disease patients, using 2D and 3D models derived from patients iPSCs.

Her current project involves investigating the pathways and network dysfunctions that lead to the formation of a-synuclein aggregates in different synucleinopathies using 3D models of cortical and dopaminergic neurons derived from patients’ iPSCs.